InvestorsHub Logo
Followers 34
Posts 4311
Boards Moderated 0
Alias Born 07/16/2014

Re: shortridge3w post# 108199

Monday, 06/12/2017 1:23:37 PM

Monday, June 12, 2017 1:23:37 PM

Post# of 458436
It's a quote from Daniela Semedo, PhD at Alzheimer'snewstoday.

https://alzheimersnewstoday.com/2017/06/12/anavex-life-sciences-presents-new-information-on-alzheimers-therapy-anavex-2-73/

"The trial’s key finding was that none of the 32 patients who were treated experienced cognitive decline. Measures of brain activity, depressions and daily functioning were also stable during the treatment period."


------

"Patients’ mental acuity and ability to manage everyday tasks were evaluated at the start of the study. At the end, none of the 32 patients showed cognitive decline. "

https://alzheimersnewstoday.com/2016/11/22/anavex-experimental-alzheimers-treatment-halts-cognitive-decline/

I'm absolutely dumbfounded. I wonder how many current investors have invested based on the Dr's articles.

Wow! Just Wow!

Perhaps Anavex should give a significant raise to whomever made those slide decks for the presentations.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News